- Home
- PZG vs IBIO Comparison
PZG vs IBIO Comparison
Compare PZG & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PZG
- IBIO
- Stock Information
- Founded
- PZG 1992
- IBIO 2008
- Country
- PZG United States
- IBIO United States
- Employees
- PZG N/A
- IBIO N/A
- Industry
- PZG Metal Mining
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- PZG Basic Materials
- IBIO Health Care
- Exchange
- PZG Nasdaq
- IBIO Nasdaq
- Market Cap
- PZG 26.3M
- IBIO 23.4M
- IPO Year
- PZG 1999
- IBIO N/A
- Fundamental
- Price
- PZG $0.44
- IBIO $2.30
- Analyst Decision
- PZG
- IBIO Strong Buy
- Analyst Count
- PZG 0
- IBIO 2
- Target Price
- PZG N/A
- IBIO $4.30
- AVG Volume (30 Days)
- PZG 250.7K
- IBIO 97.9K
- Earning Date
- PZG 11-12-2024
- IBIO 11-12-2024
- Dividend Yield
- PZG N/A
- IBIO N/A
- EPS Growth
- PZG N/A
- IBIO N/A
- EPS
- PZG N/A
- IBIO N/A
- Revenue
- PZG N/A
- IBIO $175,000.00
- Revenue This Year
- PZG N/A
- IBIO N/A
- Revenue Next Year
- PZG N/A
- IBIO N/A
- P/E Ratio
- PZG N/A
- IBIO N/A
- Revenue Growth
- PZG N/A
- IBIO 250.00
- 52 Week Low
- PZG $0.30
- IBIO $0.25
- 52 Week High
- PZG $0.69
- IBIO $6.20
- Technical
- Relative Strength Index (RSI)
- PZG 60.98
- IBIO 40.07
- Support Level
- PZG $0.34
- IBIO $2.40
- Resistance Level
- PZG $0.45
- IBIO $2.65
- Average True Range (ATR)
- PZG 0.03
- IBIO 0.21
- MACD
- PZG 0.01
- IBIO -0.07
- Stochastic Oscillator
- PZG 92.59
- IBIO 27.49
About PZG Paramount Gold Nevada Corp.
Paramount Gold Nevada Corp is an exploration-stage mining company. Together with its subsidiaries, it is engaged in the business of acquiring, exploring, and developing precious metal projects in the United States. Also, it explores for gold and silver. It enhances the value of projects by implementing exploration and engineering programs that are likely to expand and upgrade known mineralized material to reserves. Paramount tries to realize the value of its projects by selling its projects to producers; joint venturing its projects with other companies; or building and operating small mines on its own. Its projects include sleeper gold, grassy mountain gold, frost project; other non-material, and mineral resources.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.